ce - 医索

找到约 2062 条结果

ACE-Breast-02 a pivotal phase lllll trial of ARX788, anovel anti-HER2 ADC, vs lapatinib plus capecitabine forHER2 advanced breast cancer

医客学院 - 会议报告集

Abemaciclib plus fulvestrant vs fulvestrant alone for HR HER2-advanced breast cancer following progression onprior CDK46 inhibitor plus endocrine therapy Primaryoutcome of the Phase 3 postMONARCH

医客学院 - 会议报告集

A Randomized, Multicenter, Open-label, Phase lll Trial ComparingAnthracyclines Followed by Taxane Versus Anthracyclines Followedby Taxane Plus Carboplatin as (Neo) Adjuvant Therapy in Patientswith

医客学院 - 会议报告集

Taiwan National Lung Cancer Early Detection Program for HeavySmokers and Non-smokers with Family History of Lung Cancer

医客学院 - 会议报告集

Subcutaneous amivantamab vs intravenous amivantamabboth in combination with lazertinib, in refractoryEGFR-mutated,advanced non-small cell lung cancer

医客学院 - 会议报告集

STRIKING THE BALANCE WITH NEXTGENERATION TARGETED THERAPIESFOR ALK AND EGFR

医客学院 - 会议报告集

Sparking the ConversationIntegrating ctDNA and Quality ofLife in Adjuvant Lung Cancer Care

医客学院 - 会议报告集

Smoking history requirement and lungcancer screening eligibility disparities.

医客学院 - 会议报告集

Safety and efficacy of osimertinib plus consolidativestereotactic ablative radiation(SABR) inadvanced EGFR mutant non-small cell lungcancer(NSCLC)results from a multi-center Phase ltrial

医客学院 - 会议报告集

Sacituzumab Tirumotecan (sac-TMT; Also Known asSKB264MK-2870)in Combination With KL-A167 (Anti-PD-L1)as First-Line Treatment for Patients With Advanced NSCLCFrom the Phase ll OptiTRoP-Lung01 Study

医客学院 - 会议报告集

今日实时热搜